Radiation-induced intestinal damage: latest molecular and clinical developments
- PMID: 31746639
- DOI: 10.2217/fon-2019-0416
Radiation-induced intestinal damage: latest molecular and clinical developments
Abstract
Aim: To systematically review the prophylactic and therapeutic interventions for reducing the incidence or severity of intestinal symptoms among cancer patients receiving radiotherapy. Materials & methods: A literature search was conducted in the PubMed database using various search terms, including 'radiation enteritis', 'radiation enteropathy', 'radiation-induced intestinal disease', 'radiation-induced intestinal damage' and 'radiation mucositis'. The search was limited to in vivo studies, clinical trials and meta-analyses published in English with no limitation on publication date. Other relevant literature was identified based on the reference lists of selected studies. Results: The pathogenesis of acute and chronic radiation-induced intestinal damage as well as the prevention and treatment approaches were reviewed. Conclusion: There is inadequate evidence to strongly support the use of a particular strategy to reduce radiation-induced intestinal damage. More high-quality randomized controlled trials are required for interventions with limited evidence suggestive of potential benefits.
Keywords: cancer; intestinal damage; ionizing radiation; radiation enteritis; radiation enteropathy.
Similar articles
-
Review article: new insights into the pathogenesis of radiation-induced intestinal dysfunction.Aliment Pharmacol Ther. 2000 May;14(5):523-8. doi: 10.1046/j.1365-2036.2000.00745.x. Aliment Pharmacol Ther. 2000. PMID: 10792113 Review.
-
Radiation damage to the small intestine.World J Surg. 1986 Apr;10(2):189-94. doi: 10.1007/BF01658135. World J Surg. 1986. PMID: 3705603 No abstract available.
-
[Radiation-induced intestinal injury].Ter Arkh. 2025 Mar 26;97(2):101-108. doi: 10.26442/00403660.2025.02.203116. Ter Arkh. 2025. PMID: 40237744 Review. Russian.
-
Ghrelin reverts intestinal stem cell loss associated with radiation-induced enteropathy by activating Notch signaling.Phytomedicine. 2021 Jan;81:153424. doi: 10.1016/j.phymed.2020.153424. Epub 2020 Nov 26. Phytomedicine. 2021. PMID: 33278782
-
Radiation enteropathy--incidence, aetiology, risk factors, pathology and symptoms.Tumori. 1995 May-Jun;81(3 Suppl):122-5. Tumori. 1995. PMID: 7571042 Review.
Cited by
-
Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.In Vivo. 2024 Jul-Aug;38(4):1636-1648. doi: 10.21873/invivo.13613. In Vivo. 2024. PMID: 38936936 Free PMC article.
-
Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury.Mol Med. 2024 Jul 19;30(1):105. doi: 10.1186/s10020-024-00873-0. Mol Med. 2024. PMID: 39030525 Free PMC article. Review.
-
Clinical Evidence and Potential Mechanisms in Treating Radiation Enteritis with Modified Baitouweng Decoction.Evid Based Complement Alternat Med. 2023 Jan 30;2023:9731315. doi: 10.1155/2023/9731315. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36756038 Free PMC article. Review.
-
Autophagy Induced by Micheliolide Alleviates Acute Irradiation-Induced Intestinal Injury via Inhibition of the NLRP3 Inflammasome.Front Pharmacol. 2022 Jan 18;12:773150. doi: 10.3389/fphar.2021.773150. eCollection 2021. Front Pharmacol. 2022. PMID: 35115927 Free PMC article.
-
P38 MAPK and Radiotherapy: Foes or Friends?Cancers (Basel). 2023 Jan 30;15(3):861. doi: 10.3390/cancers15030861. Cancers (Basel). 2023. PMID: 36765819 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical